Annual Interest Expense
$2.26 M
+$996.00 K+78.80%
01 December 2023
Summary:
Sinovac Biotech annual interest expense is currently $2.26 million, with the most recent change of +$996.00 thousand (+78.80%) on 01 December 2023. During the last 3 years, it has risen by +$807.00 thousand (+55.54%). SVA annual interest expense is now -33.67% below its all-time high of $3.41 million, reached on 31 December 2014.SVA Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
N/A
01 June 2024
Summary:
Sinovac Biotech quarterly interest expense is not available.SVA Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
N/A
01 June 2024
Summary:
Sinovac Biotech TTM interest expense is not available.SVA TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SVA Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +55.5% | - | - |
| 5 y5 years | +111.2% | - | - |
SVA Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -20.3% | +78.8% | ||||
| 5 y | 5 years | -20.3% | +247.7% | ||||
| alltime | all time | -33.7% | +488.5% |
Sinovac Biotech Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $2.26 M(+78.8%) | - | - |
| Dec 2022 | $1.26 M(-55.4%) | - | - |
| Dec 2021 | $2.84 M(+95.2%) | - | - |
| Dec 2020 | $1.45 M(+123.5%) | $328.00 K(-38.2%) | $1.45 M(+13.2%) |
| Sept 2020 | - | $531.00 K(+42.4%) | $1.28 M(+42.7%) |
| June 2020 | - | $373.00 K(+68.8%) | $900.00 K(+29.9%) |
| Mar 2020 | - | $221.00 K(+39.0%) | $693.00 K(+6.6%) |
| Dec 2019 | $650.00 K(-39.3%) | $159.00 K(+8.2%) | $650.00 K(-1.1%) |
| Sept 2019 | - | $147.00 K(-11.4%) | $657.00 K(-14.0%) |
| June 2019 | - | $166.00 K(-6.7%) | $764.00 K(-13.2%) |
| Mar 2019 | - | $178.00 K(+7.2%) | $880.00 K(-17.8%) |
| Dec 2018 | $1.07 M(-31.8%) | $166.00 K(-34.6%) | $1.07 M(+18.4%) |
| Sept 2018 | - | $254.00 K(-9.9%) | $904.00 K(+39.1%) |
| June 2018 | - | $282.00 K(-23.4%) | $650.00 K(+76.6%) |
| Mar 2018 | - | $368.00 K(-37.9%) | $368.00 K(-78.7%) |
| Dec 2017 | $1.57 M(-9.3%) | - | - |
| Dec 2016 | $1.73 M(-9.9%) | $593.00 K(+68.5%) | $1.73 M(+11.3%) |
| Sept 2016 | - | $352.00 K(-12.2%) | $1.55 M(-8.3%) |
| June 2016 | - | $401.00 K(+4.7%) | $1.70 M(-1.2%) |
| Mar 2016 | - | $383.00 K(-8.4%) | $1.72 M(-10.7%) |
| Dec 2015 | $1.92 M(-43.6%) | $418.00 K(-15.2%) | $1.92 M(-20.7%) |
| Sept 2015 | - | $493.00 K(+17.1%) | $2.42 M(-14.5%) |
| June 2015 | - | $421.00 K(-28.4%) | $2.83 M(-12.7%) |
| Mar 2015 | - | $588.00 K(-36.1%) | $3.25 M(-4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | $3.41 M(+12.4%) | $920.00 K(+1.7%) | $3.41 M(+1.7%) |
| Sept 2014 | - | $905.00 K(+8.8%) | $3.35 M(+5.3%) |
| June 2014 | - | $832.00 K(+10.9%) | $3.18 M(+2.0%) |
| Mar 2014 | - | $750.00 K(-13.1%) | $3.12 M(+2.9%) |
| Dec 2013 | $3.03 M(+291.1%) | $863.00 K(+17.4%) | $3.03 M(+8.3%) |
| Sept 2013 | - | $735.00 K(-4.5%) | $2.80 M(+35.6%) |
| June 2013 | - | $770.00 K(+16.1%) | $2.06 M(+35.2%) |
| Mar 2013 | - | $663.00 K(+5.0%) | $1.53 M(+41.6%) |
| Dec 2012 | $775.00 K(+101.8%) | $631.40 K(+172.0%) | $1.08 M(+90.6%) |
| June 2012 | - | $232.10 K(+8.3%) | $565.40 K(-16.4%) |
| Mar 2012 | - | $214.30 K(-444.0%) | $676.10 K(+27.2%) |
| Dec 2011 | $384.00 K(-67.4%) | -$62.30 K(-134.4%) | $531.50 K(-50.3%) |
| Sept 2011 | - | $181.30 K(-47.1%) | $1.07 M(+2.5%) |
| June 2011 | - | $342.80 K(+391.8%) | $1.04 M(-7.1%) |
| Mar 2011 | - | $69.70 K(-85.3%) | $1.12 M(-4.6%) |
| Dec 2010 | $1.18 M(+120.4%) | $475.00 K(+205.1%) | $1.18 M(+76.8%) |
| Sept 2010 | - | $155.70 K(-63.2%) | $666.20 K(-11.9%) |
| June 2010 | - | $423.00 K(+240.0%) | $756.50 K(+42.0%) |
| Mar 2010 | - | $124.40 K(-437.1%) | $532.60 K(-0.3%) |
| Dec 2009 | $534.50 K(-23.8%) | -$36.90 K(-115.0%) | $534.40 K(-6.5%) |
| Sept 2009 | - | $246.00 K(+23.6%) | $571.30 K(+75.6%) |
| June 2009 | - | $199.10 K(+57.8%) | $325.30 K(+157.8%) |
| Mar 2009 | - | $126.20 K(-20.0%) | $126.20 K(-20.0%) |
| Dec 2008 | $701.60 K | - | - |
| Mar 2008 | - | $157.70 K | $157.70 K |
FAQ
- What is Sinovac Biotech annual interest expense?
- What is the all time high annual interest expense for Sinovac Biotech?
- What is the all time high quarterly interest expense for Sinovac Biotech?
- What is the all time high TTM interest expense for Sinovac Biotech?
What is Sinovac Biotech annual interest expense?
The current annual interest expense of SVA is $2.26 M
What is the all time high annual interest expense for Sinovac Biotech?
Sinovac Biotech all-time high annual interest expense is $3.41 M
What is the all time high quarterly interest expense for Sinovac Biotech?
Sinovac Biotech all-time high quarterly interest expense is $920.00 K
What is the all time high TTM interest expense for Sinovac Biotech?
Sinovac Biotech all-time high TTM interest expense is $3.41 M